Cargando…
Stakeholder perception of pharmaceutical value: A multicriteria decision analysis pilot case study for value assessment in the United States
BACKGROUND: Recent attention to value frameworks has highlighted limitations of current conventional value and health technology assessment (V/HTA) methods (eg, cost-effectiveness). Multicriteria decision analysis (MCDA) has potential as a supplemental tool to incorporate additional value criteria i...
Autores principales: | Mendola, Nicholas D, Oehrlein, Elisabeth, Perfetto, Eleanor M, Westrich, Kimberly, McQueen, Robert Brett |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372975/ https://www.ncbi.nlm.nih.gov/pubmed/36125060 http://dx.doi.org/10.18553/jmcp.2022.28.10.1190 |
Ejemplares similares
-
Payer perceptions and use of value assessment tools in the United States
por: Westrich, Kimberly, et al.
Publicado: (2023) -
Underestimating the Value of an Intervention: The Case for Including Productivity in Value Assessments and Formulary Design
por: Karmarkar, Taruja, et al.
Publicado: (2020) -
Increasing uptake of comparative effectiveness and patient-centered outcomes research among stakeholders: insights from conference discussion
por: Law, Ernest, et al.
Publicado: (2018) -
Multicriteria Decision-Making Approach with Hesitant Interval-Valued Intuitionistic Fuzzy Sets
por: Peng, Juan-juan, et al.
Publicado: (2014) -
Multicriteria Group Decision Making by Using Trapezoidal Valued Hesitant Fuzzy Sets
por: Rashid, Tabasam, et al.
Publicado: (2014)